On the heels of Tezspire approval in US, Amgen will add filling line in Ireland
On the heels of a big FDA approval last week for its keystone asthma drug, Amgen is adding on at its Irish manufacturing site.
Amgen’s site in Dún Laoghaire is about to get a $100 million upgrade to improve its formulation, aseptic drug product filling, lyophilisation and packaging operations as the company celebrates its 10th year in Ireland. The addition will add another 150 jobs for construction workers in the Dublin suburb. The project is set to be the company’s largest outside of North America.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,600+ biopharma pros reading Endpoints daily — and it's free.